Tegocap Tablet 50 mg (Tegoprazan)

Adult dose

1. Treatment of erosive gastroesophageal reflux disease Administer 50 mg orally once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, administer for an additional 4 weeks. 2. Treatment of non-erosive gastroesophageal reflux disease Administer 50 mg orally once daily for 4 weeks. 3. Treatment of gastric ulcers Administer 50 mg orally once daily for 8 weeks. 4. Combination therapy with antibiotics for Helicobacter pylori eradication in patients with peptic ulcers and/or chronic atrophic gastritis Patients with Helicobacter pylori infection should receive eradication therapy. Administer this product 50 mg, amoxicillin 1 g, and clarithromycin 500 mg orally twice daily for 7 days. 5. Maintenance therapy following treatment of erosive gastroesophageal reflux disease <25mg only> Administer 25 mg orally once daily. This product may be administered with or without food.

This medicine should not be used in patients who are allergic to this medicine or its components or who have experienced hypersensitivity reactions. This medication should not be administered to patients taking specific antiviral agents such as atazanavir, nelfinavir, or rilpivirine. It should also not be used in pregnant or breastfeeding women. Caution should be exercised when using this medication in patients with liver or kidney function issues, and elderly patients should take it carefully. Gastrointestinal disturbances such as nausea, diarrhea, or dyspepsia may occur during treatment, and neurological symptoms such as infection symptoms, headaches, or dizziness have also been reported. Long-term use may lead to vitamin B12 deficiency, and regular testing is recommended. As this medication suppresses gastric acid secretion, long-term use may increase the risk of infections due to bacterial overgrowth in the stomach. During treatment, the physician should check for serious diseases such as gastric ulcers or stomach cancer, and patients with osteoporosis should use the minimal dose and duration to consider the risk of fractures. This medication may interact with other drugs; therefore, patients taking antiviral agents, antifungals, iron preparations, or certain chemotherapeutic agents should inform their doctor or pharmacist. Pregnant or breastfeeding women should not use this medication, and safety in children or adolescents has not been established. No specific overdose symptoms have been reported, but if symptoms appear, immediate medical attention should be sought. Keep this medication out of reach of children and do not transfer it to other containers. The effects of this medication on driving or operating machinery are not clearly established, but caution should be exercised considering the patient's condition and adverse reactions.

nausea, diarrhea, dyspepsia, nasopharyngitis, viral upper respiratory infection, chest discomfort, epigastric pain, abdominal discomfort, constipation, abdominal pain, abdominal distension, vomiting, belching, lower abdominal pain, gastric ulcer, anal bleeding, erosive duodenitis, bloating, gastric polyp, gastroesophageal reflux disease, intestinal metaplasia, hematemesis, hemorrhoids, melena, folliculitis, bacterial gastroenteritis, latent tuberculosis, increased alanine aminotransferase, increased gamma-glutamyl transferase, increased blood bilirubin, increased aspartate aminotransferase, increased blood creatine phosphokinase, presence of hematuria, positive urine red blood cells, increased blood gastrin, increased blood triglycerides, fatigue, ligament sprain, concussion, abrasion, foot fracture, joint injury, muscle strain, myalgia, arthralgia, tendinitis, headache, dizziness, vascular edema, dermatitis, seborrheic dermatitis, cough, oropharyngeal pain, throat irritation, vaginal discharge, vulvar pruritus, breast calcification, adenomyosis, ovarian cyst, bile duct stone, hepatic cyst, overactive bladder, nocturia, renal cyst, gastric adenocarcinoma, breast cancer, gastrointestinal adenoma, uterine leiomyoma, premature ventricular contraction, lymphadenitis, anemia, insomnia, dental implant, otalgia, diabetes mellitus, hypertension, thyroid cyst, diarrhea, taste disorder, urticaria, dry mouth, anal incontinence, duodenitis, blood in stools, oral sensory disturbance, migraine, drowsiness, pruritus, erythema, rash, drug eruption, toxic skin rash, cystitis, shingles, miliaria, sinusitis, tonsillitis, weakness, chest pain, lower back pain, musculoskeletal stiffness, voice disorders, palpitations, flushing, facial flushing, choroiditis, retinal disorders, laryngeal ulceration, wet cough, chronic urticaria, diastolic dysfunction, hearing loss, thyroid mass, hepatic steatosis, nephrolithiasis, erosive gastritis, chronic gastritis, facial paralysis, sensory disturbances, bronchitis, periodontitis, scoliosis, musculoskeletal discomfort, intervertebral disc disorder of the spine, osteoporosis, contusion, pelvic fracture, skin abrasion, dental fracture, wrist fracture

This medicine may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the medicine's efficacy and safety over time.

Appearance

Light pink oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle